CONFERENCE COVERAGE
American College of Chest Physicians
Annual Meeting
- COPD Exacerbation Risk May Be Increased by Delayed Start of Triple Therapy
- Severe COVID-19 Is Associated With Post-Discharge ILD in Patients Without Cancer
- COPD Severity Appears Not to Affect CABG Mortality
- Cannabis Use Linked to Fewer Acute Exacerbations of COPD
- Omalizumab Improves Outcomes in Allergic Asthma Even With Off-Label Dosing
- Triple Therapy Linked to Fewer Exacerbations in COPD With Elevated Eosinophils
- Robotic-Assisted Bronchoscopy With Cone-Beam CT Imaging to Assess Lung Lesions
- Extracorporeal Membrane Oxygenation Increases Risk in Certain Comorbidities
- Statin Use May Reduce Risk for Lung Cancer in Patients With IPF
- Rituximab Significantly Reduces PASP in ILD-SSc
- Upfront Empiric CAP Antimicrobial Therapy Linked to Less VAP in Severe COVID-19
- Dupilumab Reduces Oral Corticosteroid Use in OCS-Dependent Severe Asthma
Latest Tweets
Follow
@PulmAdvisor
Conference Coverage from
